Keratoconjunctivitis Sicca
Showing NaN - NaN of 8
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- 0.05% Voclosporin Ophthalmic Solution (VOS)
- +3 more
-
Newport Beach, California
- +8 more
Dec 8, 2021
Keratoconjunctivitis Sicca, Dry Eye Disease Trial in United States (Lifitegrast, Placebo)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- Lifitegrast
- Placebo
-
Waterbury, Connecticut
- +12 more
Jun 2, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Phoenix, Arizona
- +59 more
Jan 19, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121, Placebo)
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121
- Placebo
-
Artesia, California
- +10 more
Jan 4, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Birmingham, Alabama
- +61 more
Dec 10, 2020
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in Phoenix, Andover, Memphis (Intranasal Lacrimal Neurostimulator (Oculeve))
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- Intranasal Lacrimal Neurostimulator (Oculeve)
-
Phoenix, Arizona
- +2 more
Sep 27, 2017
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (rebamipide 2% ophthalmic suspension, eye drops)
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- rebamipide 2% ophthalmic suspension
- placebo eye drops
-
Waterbury, Connecticut
- +4 more
Jan 9, 2012